alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Incentive and Retention



 Exhibit 10.6.1 
  
 Incentive and Retention Program 
  
 Under the Company’s Incentive and Retention Program adopted by the Compensation Committee of the Board of Directors of the Company on May 19, 2003, certain employees
and officers and the contracted corporate counsel of the Company are entitled to receive a bonus, based upon such individual’s pro rata portion of the stock options granted to such individual on or around May 22, 2003, (i) within thirty days of
completion of the sale of all or substantially all of the assets or stock of the business of the Company or a merger of the Company with another company pursuant to which the consideration per share received by the Company’s shareholders meets
certain thresholds described in the program, or (ii) within thirty days of the completion of a secondary underwritten public offering pursuant to which the proceeds received by the Company and offering price of the common stock meets certain
thresholds described in the program. The maximum aggregate bonus payable by the Company under the program is $2,236,962. Under the program, if the Company’s Board of Directors determines in its discretion that the Company is unable to pay
applicable bonus awards in cash, it shall pay such awards in securities of the Company’s stock before the transaction, or in the purchaser’s stock thereafter, or substantially similar securities. 
  
 Annual Incentive Bonuses 
  
 On March 26, 2003 the Compensation Committee of the Board of Directors of PlanVista
Corporation adopted Annual Incentive Bonus targets for each of its senior officers in keeping with the Company’s annual bonus compensation practices. The senior officers of the Company are entitled to receive a cash bonus based on certain
financial, business and personal goals as set forth in each individual senior officer’s 2003 Annual Incentive Planning Worksheet. The Board of Directors reserved the right to pay 20% of the senior officers’ bonuses in registered shares of
Company Common Stock. As disclosed in the Company’s Proxy Statement for the 2003 Annual Meeting of Stockholders, the Compensation Committee approved bonuses for Messrs. Dingle and Markle in the event of a change of control of the Company. In
November 2003 the Compensation Committee approved an additional $150,000 bonus to Mr. Dingle in connection with a change of control under certain specified circumstances. 
  
 The Company also awards Annual Incentive Bonuses for certain employees of the Company, based on specified financial, business and personal
goals set forth in each individual employee’s 2003 Annual Incentive Planning Worksheet. 
  

 23
----

            COMMISSION REGULATION (EC) No 703/2005

of 4 May 2005         

fixing the compensatory aid for bananas produced and marketed in the Community in 2004 and the unit value of the advances for 2005

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Regulation (EEC) No 404/93 of 13 February 1993 on the common organisation of the market in bananas (1), and in particular the first subparagraph of Article 12(6) and Article 14 thereof,

Whereas:

HAS ADOPTED THIS REGULATION:

Article 1

1.   The compensatory aid provided for in Article 12 of Regulation (EEC) No 404/93 for fresh bananas falling within CN code ex 0803, excluding plantain bananas, produced and marketed in the Community in 2004 shall be EUR 28,1 per 100 kilograms.

2.   The aid fixed in paragraph 1 shall be increased by EUR 7,82 per 100 kilograms for bananas produced in Martinique and by EUR 8,18 per 100 kilograms for bananas produced in Guadeloupe.

Article 2

The advance for bananas marketed from January to December 2005 shall amount to EUR 19,67 per 100 kilograms. The relevant security shall be EUR 9,84 per 100 kilograms.

Article 3

Notwithstanding Article 10 of Regulation (EEC) No 1858/93, the competent authorities of the Member States shall pay the balance of the compensatory aid to be granted in respect of 2004 and the advance for bananas marketed during January and February 2005 within two months of the entry into force of this Regulation, after the verifications provided for in Article 10 of Regulation (EEC) No 1858/93.

Article 4

This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 4 May 2005.

For the Commission

Mariann FISCHER BOEL            

Member of the Commission

----

(1)OJ L 47, 25.2.1993, p. 1. Regulation as last amended by Commission Regulation (EC) No 2587/2001 (OJ L 345, 29.12.2001, p. 13).

(2)OJ L 170, 13.7.1993, p. 5. Regulation as last amended by Commission Regulation (EC) No 471/2001 (OJ L 67, 9.3.2001, p. 52).

----
§ 14.800 Purpose. Sections 14.800 through 14.810 establish policy, assign responsibilities and prescribe procedures with respect to: ( a ) The production or disclosure of official information or records of the Department of Veterans Affairs (VA); and
( b ) The testimony of present or former VA personnel relating to any official information acquired by any individual as part of that individual's performance of official duties, or by virtue of that individual's official status, in federal, state or other legal proceedings covered by these regulations.
(Authority: 38 U.S.C. 501(a) and (b); 5 U.S.C. 301)
# Official Journal C 332A/30 D

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 332A |
| | |
| English edition | Information and Notices | Volume 4930 December 2006 |

ISSN 1725-2423

Official Journal

of the European Union

C 332A

English edition

Information and Notices

Volume 4930 December 2006

---

| Notice No | Contents | page |
| --- | --- | --- |
| | III   Notices |
| | European Personnel Selection Office (EPSO) |
| 2006/C 332A/1 | Reserve list — Open Competition EPSO/AD/27/05 — Administrators (AD5) in the field of audit | 1 |

Notice No

Contents

page

III   Notices

European Personnel Selection Office (EPSO)

2006/C 332A/1

Reserve list — Open Competition EPSO/AD/27/05 — Administrators (AD5) in the field of audit

1

---

| EN | |
| --- | --- |

EN
HomeOffice of the SpokespersonPress Releases...Designation of Former Colombian Senator Luis Alberto Gil Castillo for Involvement in Significant Corruption

# 									Designation of Former Colombian Senator Luis Alberto Gil Castillo for Involvement in Significant Corruption							

Press Statement

Ned Price, Department Spokesperson

June 30, 2022

The United States is designating former Colombian Senator Luis Alberto Gil Castillo for his involvement in significant corruption.  Gil Castillo solicited and accepted monetary bribes from a subgroup of the then-U.S.-designated foreign terrorist organization (FTO) known as the Autodefensas Unidas de Colombia (AUC). The bribe was accepted in exchange for exercising undue political influence in his official capacity as a member of the Colombian Senate. In addition, Gil Castillo later attempted to bribe a witness in a criminal case against him.  These actions undermined the stability of Colombia’s democratic institutions and the security of the United States against transnational crime and terrorism.

This public designation is made under Section 7031(c) of the Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022. Under this authority, designated officials of foreign governments involved in significant corruption and their immediate family members are generally ineligible for entry into the United States.  The Department is also designating Gil Castillo’s spouse Doris Clemencia Vega Quiróz.  These designations follow the U.S. designation under Section 7031(c) in December 2021 of Gil Castillo’s associate, Carlos Julián Bermeo Casas, a former Colombian prosecutor, for engaging in significant corruption.

Today’s actions reinforce Colombia’s own law enforcement and judicial actions against Gil Castillo and reaffirm the commitment of the United States to combat corruption.  The United States continues to stand with all Colombians in support of democracy, the rule of law, and will continue to hold accountable those who abuse public power for personal gain.

Tags

7031(c)Bureau of Western Hemisphere AffairsColombiaCountering TerrorismOffice of the SpokespersonTerrorism

## Related Articles

-  											 									
Read more
 

Back to Top
Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 5 is placed in the separate grouping of parts pertaining to patents regulations.

§ 42.12 Sanctions. ( a ) The Board may impose a sanction against a party for misconduct, including: ( 1 ) Failure to comply with an applicable rule or order in the proceeding;
( 2 ) Advancing a misleading or frivolous argument or request for relief;
( 3 ) Misrepresentation of a fact;
( 4 ) Engaging in dilatory tactics;
( 5 ) Abuse of discovery;
( 6 ) Abuse of process; or
( 7 ) Any other improper use of the proceeding, including actions that harass or cause unnecessary delay or an unnecessary increase in the cost of the proceeding.
( b ) Sanctions include entry of one or more of the following: ( 1 ) An order holding facts to have been established in the proceeding;
( 2 ) An order expunging or precluding a party from filing a paper;
( 3 ) An order precluding a party from presenting or contesting a particular issue;
( 4 ) An order precluding a party from requesting, obtaining, or opposing discovery;
( 5 ) An order excluding evidence;
( 6 ) An order providing for compensatory expenses, including attorney fees;
( 7 ) An order requiring terminal disclaimer of patent term; or
( 8 ) Judgment in the trial or dismissal of the petition.
# OAR Box 1112 Prepped by Ryan Dugan



## Document

Number: 

# 8 ) ll-B-2 e Docket Number: 

# A-83-2 2

Printed 4/16/20089:12:06

AM Sheet 8of 97 P. 1

- •P. 2 

# ARGONN E NATIONA L LABORATOR Y2*> < * - - ^ 970 0 SOUTI H CAS S AVENUE , ARQONNE , IlliNOi s 6045 9 TEfEpk)N E 512/972*6 4 3 0

Apri l 1 , 198 5

Dr . Herb Needlema n Departmen t o f Psychiatry Children s Hospita l 12 5 DeSot a St . Pittsburgh , P A1521 3 Dea r Herb : O n behal f o f the U.S . EPA , I woul d lik e t o than k yo u fo r your willing
nes s t o participat e i n the lea d ris k assessmen t study . You r judgment s abou t possibl e effect s o f lea d o n the I Q o f childre n ar e criticall yneeded . Tom Wallste n an

d I ar e ver

ymuc h looking forward t o discussing thes e issue s a t ou r meetin g wit h yo u o n Wednesday , Apri l 1 7 a t 1 0 a.m . Enclose d i s a cop

yo f th

e lates t versio n o f our I Q protoco l whic h wil l be the basi s o f our intervie w sessio n wit h you . Shoul d yo u hav e an yquestion s befor e we meet , pleas e do no t hestiat e t o give m e a call . Respectfully ,
Ronal d G . Whitfiel d Decisio n an

d Syste mScience s Sectio n Energ yan d Environmenta l System s Divisio n RGWrb f Enclosur e

U.S
. DEPARTMEN T o f ENERQ Y T k UNivERsir

yo f CNC-AQ O
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS DATED MARCH 31, 1998 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                           7,050
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                11,600
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     55,018
<INVESTMENTS-CARRYING>                           1,716
<INVESTMENTS-MARKET>                             1,779
<LOANS>                                         64,392
<ALLOWANCE>                                      1,340
<TOTAL-ASSETS>                                 149,401
<DEPOSITS>                                     135,561
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                                843
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         7,455
<OTHER-SE>                                       5,542
<TOTAL-LIABILITIES-AND-EQUITY>                 149,401
<INTEREST-LOAN>                                  1,686
<INTEREST-INVEST>                                  964
<INTEREST-OTHER>                                    99
<INTEREST-TOTAL>                                 2,749
<INTEREST-DEPOSIT>                                 965
<INTEREST-EXPENSE>                                 965
<INTEREST-INCOME-NET>                            1,784
<LOAN-LOSSES>                                       30
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  1,834
<INCOME-PRETAX>                                    336
<INCOME-PRE-EXTRAORDINARY>                         336
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       230
<EPS-PRIMARY>                                     0.17
<EPS-DILUTED>                                     0.16
<YIELD-ACTUAL>                                    5.44
<LOANS-NON>                                        358
<LOANS-PAST>                                         2
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 1,313
<CHARGE-OFFS>                                       21
<RECOVERIES>                                        18
<ALLOWANCE-CLOSE>                                1,340
<ALLOWANCE-DOMESTIC>                             1,340
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                            867
        

</TABLE>
Exhibit 10.3



                               FIRST AMENDMENT TO
                MANAGEMENT SERVICES AND ADMINISTRATIVE AGREEMENT

         This  FIRST  AMENDMENT  TO  MANAGEMENT   SERVICES  AND   ADMINISTRATIVE
AGREEMENT (this "Amendment") is made effective as of the 1st day of October 2003
by and between BioDelivery Science  International,  Inc., a Delaware corporation
("BDSI"),  and Bioral  Nutrient  Delivery,  LLC, a  Delaware  limited  liability
company ("BND").

         WHEREAS,  BDSI and BND are parties to that certain Management  Services
and Administrative Agreement, dated April 1, 2003 (the "Agreement");

         WHEREAS,  pursuant to Section 18 of the  Agreement,  amendments  to the
Agreement may be made in a writings signed by BDSI and BND;

         WHEREAS,  BDSI and BND desire to amend the  Agreement in the manner set
forth in this Amendment.

         NOW,  THEREFORE,  in light of the foregoing and intending to be legally
bound, BDSI and BND hereby amend the Agreement as follows:

         1. Capitalized Terms.  Unless otherwise defined herein, all capitalized
terms used but not defined herein shall have the meanings ascribed such terms in
the Agreement.

         2.  Extension of Initial  Term. In order to effect the extension of the
Initial Term, the first sentence of Section 1 of the Agreement is hereby deleted
in its entirety and replaced with the following sentence:

         "The term of this  Agreement  shall begin as of the Effective Date and,
unless sooner  terminated in accordance with subsections (a), (b) or (c) of this
Section  1 or any  other  provision  of this  Agreement,  shall  continue  until
December 31, 2004 (such term, the "Initial Term")."

         3. No  Further  Amendment.  Except as  amended  hereby,  the  Agreement
remains unchanged and in full force and effect.




                            [Signature Page Follows]


<PAGE>


         IN WITNESS WHEREOF,  the parties hereto have executed this Agreement as
of the date first written above.


                                    BIODELIVERY SCIENCES INTERNATIONAL, INC.


                                    By:  /s/ Francis E. O'Donnell, Jr.
                                        ----------------------------------------
                                        Name:  Francis E. O'Donnell, Jr., M.D.
                                        Title:    President and CEO



                                    BIORAL NUTRIENT DELIVERY, LLC


                                    By:  /s/ James A. McNulty
                                        ----------------------------------------
                                        Name:  James A. McNulty
                                        Title:   Secretary, Treasurer and CFO


                                       2
#### § 20.1407 Rule 1407. Motions by the Board.

If the Board undertakes, on its own motion, a review pursuant to this subpart, the party to that decision and that party's representative (if any) will be notified of such motion and provided an adequate summary thereof and, if applicable, outlining any proposed discontinuance or reduction in benefits that would result from revision of the Board's prior decision. They will be allowed a period of 60 days to file a brief or argument in answer. The failure of a party to so respond does not affect the finality of the Board's decision on the motion.

(Authority: 38 U.S.C. 501(a), 7111)
Exhibit 31.1
**CERTIFICATIONS**
I, Robert S. Kendall, certify that:
1. I have reviewed this quarterly report on Form 10-QSB of Sentex SensingTechnology, Inc.;
2. Based on my knowledge, this quarterly report does not contain any untruestatement of a material fact or omit to state a material fact necessary to makethe statements made, in light of the circumstances under which such statementswere made, not misleading with respect to the period covered by this quarterlyreport;
3. Based on my knowledge, the financial statements, and other financialinformation included in this quarterly report, fairly present in all materialrespects the financial condition, results of operations and cash flows of theregistrant as of, and for, the periods presented in this quarterly report;
4. The registrant’s other certifying officers and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-14 and 15d-14) for the registrant and we have:
a) designed such disclosure controls and procedures to ensure that materialinformation relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this quarterly report is being prepared;
b) evaluated the effectiveness of the registrant’s disclosure controls andprocedures as of a date within 90 days prior to the filing date of thisquarterly report (the “Evaluation Date”); and
c) presented in this quarterly report our conclusions about the effectivenessof the disclosure controls and procedures based on our evaluation as of theEvaluation Date;
5. The registrant’s other certifying officers and I have disclosed, based onour most recent evaluation, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performing theequivalent function):
a) all significant deficiencies in the design or operation of internalcontrols which could adversely affect the registrant’s ability to record,process, summarize and report financial data and have identified for theregistrant’s auditors any material weaknesses in internal controls; and
b) any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal controls;and
6. The registrant’s other certifying officers and I have indicated in thisquarterly report whether or not there were significant changes in internalcontrols or in other factors that could significantly affect internal controlssubsequent to the date of our most recent evaluation, including any correctiveactions with regard to significant deficiencies and material weaknesses.
Date: October 5, 2004
/s/ Robert S. Kendall, Chief Executive Officer
#### §§ 19.56-19.74 [Reserved]
#### § 480.109 Applicability of other statutes and regulations.

The provisions of 42 U.S.C. 290dd-3 and 290ee-3 governing confidentiality of alcohol and drug abuse patients' records, and the implementing regulations at 42 CFR part 2, are applicable to QIO information.

[50 FR 15359, Apr. 17, 1985; 50 FR 41887, Oct. 16, 1985. Redesignated at 64 FR 66279, Nov. 24, 1999]
Exhibit
      32.2


**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002





In
      connection with the quarterly report of Bel Fuse Inc (the "Company") on Form
      10-Q for the quarter ended June 30, 2008 filed with the Securities and Exchange
      Commission (the "Report"), I, Colin Dunn, Vice President of Finance of the
      Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
      Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
      The
      Report fully complies with the requirements of Section 13(a) of the Securities
      Exchange Act of 1934; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the consolidated financial condition of the Company as of the dates presented
      and consolidated result of operations of the Company for the periods presented.





Dated:
      August 8, 2008





BY:
            /s/
                Colin DunnColin
                Dunn, Vice President ofFinance